三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
特瑞普利单抗获国际权威指南认证助推海外放量
特瑞普利单抗获国际权威指南认证助推海外放量
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:150KB
图片尺寸:2257*589
同报告图片
/
4
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
所属报告:
【中邮证券】君实生物(688180)-君实生物:PD-1/VEGF联用方案有望创新引领,国际化正扬帆起航-251023(28页).pdf
打包全文图表
相关数据
截至2025年9月底,度普利尤单抗、司普奇拜单抗分别获批8项、3项适应症,且适应症持续拓展
fCDoja/nianlkI3np7AgICAgICAgfCDpgILlupTnl4cgICAgICAgICAgICAgICAgICAgICB8IOW5tOm+hOiMg+WbtCAgIHwg55uR566h5py65p6E5Y+K6I635om55pe26Ze0ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwtLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18Cnwg5bqm5pmu5Yip5bCk5Y2V5oqXICAgfCDmiJDkurrnibnlupTmgKfnmq7ngo4gICAgICAgICAgICAgfCAxOHkrICAgICAgIHwgRkRBOiAyMDE3LjAz77ybRU1BOiAyMDE3LjA577ybQ0RFOiAyMDIwLjA2ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IOW6puaZruWIqeWwpOWNleaKlyAgIHwg5ZOu5ZaYICAgICAgICAgICAgICAgICAgICAgICB8IDEyeSsgICAgICAgfCBGREE6IDIwMTguMTDvvJtFTUE6IDIwMTkuMDXvvJtDREU6IDIwMjMuMTEgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8Cnwg5bqm5pmu5Yip5bCk5Y2V5oqXICAgfCDpnZLlsJHlubTnibnlupTmgKfnmq7ngo4gICAgICAgICAgIHwgMTIgLSAxOHkgICB8IEZEQTogMjAxOS4wM++8m0VNQTogMjAxOS4wOO+8m0NERTogMjAyMS4wOSAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCDluqbmma7liKnlsKTljZXmipcgICB8IOaFouaAp+m8u+eqpueCjuS8tOm8u+aBr+iCiSAgICAgICAgIHwgMTh5KyAgICAgICB8IEZEQTogMjAxOS4wNu+8m0VNQTogMjAxOS4xMCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IOW6puaZruWIqeWwpOWNleaKlyAgIHwg5YS/56ul54m55bqU5oCn55qu54KOICAgICAgICAgICAgIHwgNiAtIDExeSAgICB8IEZEQTogMjAyMC4wNe+8m0VNQTogMjAyMC4xMe+8m0NERTogMjAyMi4wMiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCDluqbmma7liKnlsKTljZXmipcgICB8IOWXnOmFuOaAp+eykue7huiDnumjn+euoeeCjiAgICAgICAgIHwgMTJ5KyAgICAgICB8IEZEQTogMjAyMi4wNe+8m0VNQTogMjAyMy4wMSAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IOW6puaZruWIqeWwpOWNleaKlyAgIHwg5YS/56ulQUQgICAgICAgICAgICAgICAgICAgICB8IDZtIC0gNXkgICAgfCBGREE6IDIwMjIuMDbvvJtFTUE6IDIwMjMuMDLvvJtDREU6IDIwMjMuMDUgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8Cnwg5bqm5pmu5Yip5bCk5Y2V5oqXICAgfCDlpKfnlrHmgKfnsbvlpKnnlrHnlq4gICAgICAgICAgICAgfCAxOHkrICAgICAgIHwgRkRBOiAyMDI1LjA2ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCDlj7jmma7lpYfmi5zljZXmipcgICB8IOaIkOS6uueJueW6lOaAp+earueCjiAgICAgICAgICAgICB8IDE4eSsgICAgICAgfCBDREU6IDIwMjQuMDkgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCDlj7jmma7lpYfmi5zljZXmipcgICB8IOaFouaAp+m8u+eqpueCjuS8tOm8u+aBr+iCiSAgICAgICAgIHwgMTh5KyAgICAgICB8IENERTogMjAyNC4xMiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IOWPuOaZruWlh+aLnOWNleaKlyAgIHwg6L+H5pWP5oCn6by754KOICAgICAgICAgICAgICAgICB8IDE4eSsgICAgICAgfCBDREU6IDIwMjUuMDEgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8mmluc2lnaHTvvIzlm73ph5Hor4HliLjnoJTnqbbmiYDvvIjmlbDmja7miKroh7MyMDI1LzkvMzDvvIk=
收藏
行业数据
2025-12-26
原图定位
查看详情
全球范围内度普利尤单抗已有6个适应症获批上市
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
收藏
其它
2024-06-21
原图定位
查看详情
全球范围内度普利尤单抗已有5个适应症获批上市
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
收藏
其它
2024-04-19
原图定位
查看详情
特瑞普利单抗国际化注册进度
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
收藏
其它
2024-03-28
原图定位
查看详情
特瑞普利单抗美国开发上市进展复盘
5aW955qE77yM5Lul5LiL5piv5LuO5Zu+54mH5Lit5o+Q5Y+W55qE5pWw5o2u55Sf5oiQ55qE6KGo5qC877yaCgp8IOaXpeacnyAgICAgICB8IOS6i+S7tiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8LS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18CnwgMjAyMC4wMyAgICB8IOeJueeRnuaZruWIqeWNleaKl+iBlOWQiOmYv+aYlOabv+WwvOayu+eWl+m7keiJsue0oOeYpOiOt+W+l0ZEQeWtpOWEv+iNr+iupOWumiAgICAgICAgICAgICAgICB8CnwgMjAyMC4wNSAgICB8IOeJueeRnuaZruWIqeWNleaKl+ayu+eWl+m7keiJsue0oOeYpOiOt+W+l0ZEQeeqgeegtOaAp+eWl+azleiupOWumu+8m+eJueeRnuaZruWIqeWNleaKl+ayu+eWl+Wwj+e7huiDnuiCuueZjOiOt+W+l0ZEQeWtpOWEv+iNr+iupOWumiB8CnwgMjAyMC4wOSAgICB8IOeJueeRnuaZruWIqeWNleaKl+ayu+eWl+m7keiJsue0oOeYpOiOt+W+l0ZEQeaJueWHhuS4iuW4gueUs+ivt++8m+eJueeRnuaZruWIqeWNleaKl+ayu+eWl+mjn+euoemznueZjOiOt+W+l0ZEQeWtpOWEv+iNr+iupOWumiB8CnwgMjAyMS4wMSAgICB8IOeJueeRnuaZruWIqeWNleaKl+iBlOWQiOWMlueWlzFM5rK755aX6bOe54q26Z2e5bCP57uG6IOe55mM6I635b6XRkRB56qB56C05oCn55aX5rOV6K6k5a6aICAgICAgICB8CnwgMjAyMS4wMyAgICB8IOWQkUZEQea7muWKqOaPkOS6pOeJueeRnuaZruWIqeWNleaKl+ayu+eWl+mjn+euoemznueZjOeahEJMQeeUs+ivtyAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjEuMDggICAgfCBGREHlj5fnkIbnibnnkZ7mma7liKnljZXmipfmsrvnlpcxTOmjn+euoemznueZjOS7peWPiuWNleiNr+ayu+eWlzJM5Y+K5Lul5LiK6aOf566h6bOe55mM55qE5LiK5biC55Sz6K+377yb54m555Ge5pmu5Yip5Y2V5oqX5rK755aX5bCP57uG6IOe6IK655mM6I635b6XRkRB5a2k5YS/6I2v6K6k5a6aIHwKfCAyMDIxLjExICAgIHwg54m555Ge5pmu5Yip5Y2V5oqX5rK755aX5bCP57uG6IOe6IK655mM6I635b6XRkRB5om55YeG5LiK5biC55Sz6K+3ICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjIuMDQgICAgfCDnibnnkZ7mma7liKnljZXmipfmsrvnlpflsI/nu4bog57ogrrnmYzojrflvpdGREHmibnlh4bkuIrluILnlLPor7cgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAyMy4xMCAgICB8IOeJueeRnuaZruWIqeWNleaKl+ayu+eWl+Wwj+e7huiDnuiCuueZjOiOt+W+l0ZEQeaJueWHhuS4iuW4gueUs+ivtyAgICAgICAgICAgICAgICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8muWQm+WunueUn+eJqeWFrOWRiu+8jOWbvemHkeivgeWIuOeglOeptuaJgA==
收藏
其它
2024-03-15
原图定位
查看详情
全球范围内度普利尤单抗已有5个适应症获批上市
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
收藏
其它
2024-02-22
原图定位
查看详情
特瑞普利单抗美国上市历程
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
收藏
其它
2024-01-11
原图定位
查看详情
BTLA联用特瑞普利单抗治疗对比
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
收藏
其它
2023-12-19
原图定位
查看详情
特瑞普利单抗美国开发、上市进展复盘
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
收藏
其它
2023-12-14
原图定位
查看详情
特瑞普利单抗主要全球授权情况
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
收藏
行业数据
2023-11-17
原图定位
查看详情
度普利尤单抗中美欧适应症获批情况
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
收藏
行业数据
2023-04-17
原图定位
查看详情
RC48联合特瑞普利单抗对UC患者的靶病变相比基线的最佳变化
fCBIRVIyIEV4cHJlc3Npb24gfCBJSEMgMCB8IElIQyAxKyB8IElIQyAyKyB8IElIQyAzKyB8CnwtLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLXwKfCBQZXJjZW50IENoYW5nZSBmcm9tIEJhc2VsaW5lIHwgLTQwJSAgfCAtNjAlICAgfCAtODAlICAgfCAtMTAwJSAgfAoK6LWE5paZ5p2l5rqQ77ya5YWs5Y+45oub6IKh6K+05piO5Lmm77yM5Lic5YyX6K+B5Yi4
收藏
行业数据
2023-01-10
原图定位
查看详情
特瑞普利单抗黑色素瘤销售额测算
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
收藏
行业数据
2022-12-27
原图定位
查看详情
君实生物特瑞普利单抗在二线黑色素瘤治疗临床数据最优,积极拓展一线和海外市场
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
收藏
行业数据
2022-12-27
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
获多个权威指南推荐,有望加速放量。特瑞普利单抗已获得国内外十余部权威指南的推荐与认可,是首个同时获中国临床肿瘤学会(CSCO)、美国国家综合癌症网络(NCCN)以及欧洲肿瘤内科学会(ESMO)三大顶级权威指南推荐的国产抗 PD-1 单抗。
行业数据
原图定位
当前图表所属:
【中邮证券】君实生物(688180)-君实生物:PD-1/VEGF联用方案有望创新引领,国际化正扬帆起航-251023(28页).pdf
表成长能力
公司费用整体趋于稳定
公司毛利率触底反弹
公司近年归母净利润快速减亏
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》